Resource Consulting Group’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$4.89M Buy
+103,000
New +$4.33M 0.84% 7
2023
Q3
Sell
-128,000
Closed -$6.11M 61
2023
Q2
$6.11M Buy
+128,000
New +$5.77M 1.21% 7
2022
Q4
Sell
-128,000
Closed -$3.85M 42
2022
Q3
$3.85M Buy
+128,000
New +$4.46M 1.1% 5
2022
Q2
Sell
-128,000
Closed -$5.74M 69
2022
Q1
$5.74M Hold
128,000
1.99% 4
2021
Q4
$5.92M Buy
+128,000
New +$5.16M 2.09% 4

Other funds holding IRMD

Resource Consulting Group's IRMD Position: Q4 2023 in Review

Resource Consulting Group opened a new position in iRadimed (IRMD) in Q4 2023: 103,000 shares worth $4.89M. The stake represents 0.84% of the portfolio and ranks #7 among its holdings. This is a return to the name: Resource Consulting Group previously reported a position in IRMD as recently as Q2 2023.

Resource Consulting Group first reported a position in IRMD in Q4 2021 and has held it in 5 quarters since. The position peaked at $6.11M in Q2 2023. 119 funds tracked by Wall St. Rank hold IRMD as of Q4 2023.

  • Resource Consulting Group held 103,000 shares of iRadimed worth $4.89M as of Q4 2023.
  • iRadimed was a new Resource Consulting Group position in Q4 2023.
  • iRadimed made up 0.84% of Resource Consulting Group's portfolio in Q4 2023, its #7 holding.
  • Resource Consulting Group first reported a position in iRadimed in Q4 2021 and has held it in 5 quarters since.
  • Resource Consulting Group's iRadimed position peaked at $6.11M in Q2 2023.
  • 119 funds tracked by Wall St. Rank held iRadimed as of Q4 2023.

Based on Resource Consulting Group's 13F filing for Q4 2023, filed 11 Jan 2024.